Benign neoplasm of left bronchus and lung
ICD-10 D14.32 is a billable code used to indicate a diagnosis of benign neoplasm of left bronchus and lung.
D14.32 refers to a benign neoplasm located in the left bronchus and lung. These neoplasms are non-cancerous growths that can arise from various types of lung tissue, including epithelial cells, connective tissue, or other structures within the lung. Common types of benign lung neoplasms include hamartomas, adenomas, and lipomas. Although benign, these neoplasms can cause symptoms such as cough, wheezing, or obstructive pneumonia if they grow large enough to impede airflow or cause irritation. Diagnosis typically involves imaging studies such as chest X-rays or CT scans, followed by biopsy for definitive diagnosis. Surveillance is crucial, as some benign neoplasms may have the potential for malignant transformation, necessitating regular monitoring and follow-up imaging to assess growth or changes in characteristics. Treatment options may include surgical resection if the neoplasm is symptomatic or poses a risk of complications. Understanding the nature of these neoplasms is essential for appropriate management and coding.
Detailed imaging reports, biopsy results, and clinical notes describing symptoms and treatment plans.
Patients presenting with persistent cough, incidental findings on imaging, or symptoms of obstructive lung disease.
Ensure clear documentation of the neoplasm's size, location, and any changes over time to support coding and treatment decisions.
Comprehensive pathology reports, treatment history, and follow-up imaging results.
Patients with a history of lung neoplasms requiring monitoring for potential malignant transformation.
Documentation must clearly differentiate between benign and malignant findings to avoid coding errors.
Used when a benign neoplasm is surgically removed.
Operative reports detailing the procedure and findings.
Pulmonology and thoracic surgery must coordinate documentation to ensure accurate coding.
Accurate coding of D14.32 is crucial for proper reimbursement, ensuring that patients receive appropriate care and follow-up for benign lung neoplasms. It also aids in the collection of data for research and public health monitoring.
